Bio-Reference Laboratories, Inc. (NASDAQ:BRLI)

CAPS Rating: 4 out of 5

An independent clinical laboratory servicing the New York metropolitan area that offers a comprehensive list of laboratory testing services utilized by healthcare providers in the detection, diagnosis, evaluation, monitoring and treatment of diseases.

Recs

0
Player Avatar Ellumus (69.84) Submitted: 12/14/2011 5:47:43 PM : Outperform Start Price: $15.60 BRLI Score: +23.27

Bought the stock around $14 wish I found out about it earlier. Strong earnings in a weak economy, great growth stock.

Featured Broker Partners


Advertisement